Admission Date:  [**2180-3-26**]       Discharge Date:  [**2180-4-1**]  Date of Birth:   [**2118-2-15**]       Sex:  M  Service:  [**Hospital1 139**]  HISTORY OF PRESENT ILLNESS:  The patient is a 62 year old male with longstanding, severe chronic obstructive pulmonary disease, requiring home oxygen and with a recent exacerbation in [**2180-2-19**] requiring [**Hospital6 2018**]-Medicine Intensive Care Unit admission, intubation and antibiotics who presents two days after discharge to rehabilitation, with shortness of breath.
The patient was admitted to [**Hospital6 256**] on [**2180-3-2**] with shortness of breath requiring intubation and a Medicine Intensive Care Unit stay, with a course complicated by a non-Q wave myocardial infarction.
The patient was treated for ................. pneumonia and discharged to [**Hospital **] rehabilitation on [**2180-3-10**].
The patient was discharged from [**Hospital **] Rehabilitation on a medicine regimen that differed from his previously which had included chronic Prednisone 20 mg q.d.
The patient at this time of discharge from [**Hospital **] Rehabilitation was not on any chronic Prednisone dosage.
The patient denies recent fevers, chest pain, nausea, vomiting, abdominal pain, change in stools, diarrhea, constipation, dysuria, or joint pain.
ALLERGIES:  The patient has a questionable allergy to Bactrim which causes edema.
On home oxygen, 2 liters nasal cannula for 24 hours a day.
Has been on chronic Prednisone 20 mg a day for multiple months.
The patient has one daughter who lives in [**Name (NI) 16174**], her name is [**Name (NI) 19948**], the patient also has a nephew who lives in [**Name (NI) 86**] and checks in on the patient, nephew's name is [**Name (NI) **] [**Name (NI) **].
The patient was given multiple Albuterol and Atrovent nebulizers and started on intravenous steroids.
The patient's shortness of breath improved with the nebulizers and his blood pressure normalized.
Upon arrival in the Medicine Intensive Care Unit, the patient was started on biPAP and an empiric course of Levofloxacin for presumed respiratory infection.
The patient was able to be weaned off of biPAP and onto oxygen nasal cannula on the morning of hospital day #2.
As the patient had minimal shortness of breath and required nebulizers only every 4 hours he was deemed in condition for floor transfer.
Over the next four days, the patient was given a two day course of high dose Methylprednisolone and then restarted on Prednisone 40 mg q.d.
The patient was also weaned off of 4 liters nasal cannula oxygen to oxygen 2 liters nasal cannula which is the patient's home dose.
Occupational therapy noted the patient had decreased mobility, decreased cognition of safety and general deconditioning.
They recommended either longterm placement or increased services in his current home.
Physical therapy recommended either longterm placement or increased services at his current location.
The [**Hospital6 256**] House Staff, attending, care [**Hospital6 **], and social worker were concerned that the patient would be unable to handle his medicine regimen at home.
Multiple meetings were held between those individuals as well as including the [**First Name (Titles) 1587**] [**Last Name (Titles) **], the social worker from [**Name (NI) **] [**Last Name (NamePattern1) 34620**] House, and the resident nurse [**First Name8 (NamePattern2) **] [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 34620**] House.
Verapamil 120 mg p.o.
Aspirin 325 mg p.o.
Atorvastatin 10 mg p.o.
Primidone 50 mg p.o.
Imdur extended release 30 mg p.o.
Calcium Carbonate 500 mg p.o.
Cholecalciferol 400 units p.o.
Salmeterol 21 mcg one to two puffs inhaler b.i.d.
Montelukast Sodium 10 mg p.o.
Fexofenadine 60 mg p.o.
Levofloxacin 500 mg p.o.
Pantoprazole 40 mg p.o.
Ferrous Sulfate 325 mg p.o.
Prednisone 40 mg p.o.
Combivent 103/18 mcg two puffs inhaled q.
Atrovent 0.2 mg/ml solution, one ml nebulizer every 6 hours 17.
Albuterol Sulfate 0.83 mg/ml solution one nebulizer every two hours prn wheezing 18.
Albuterol Sulfate 0.83 mg/ml one nebulizer every 6 hours 19.
Albuterol Sulfate 0.83 mg/ml one to two puffs inhaled q.
